Clarivate (CLVT) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Clarivate

NYSE•Technology•Information Technology Services

$2.07-0.08(-0.04%)Market closed

Market Cap

$1.22B

P/S

0.5x

P/B

0.3x

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

How this company scores

AverageMetricSide Score: 43/100

Strongest: Balance Sheet & Red Flags (14/25); weakest: Growth (9/25).

Profitability10/25

Growth9/25

Balance Sheet & Red Flags14/25

Cash & Earnings Quality10/25

Strengths

Consistent free cash flowProfit converts from growthNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 17.5x5y range 17.5x – 17.5x

P/S · 0.5x5y range 0.5x – 2.4x

Currently below its 20-quarter median.

P/B · 0.3x5y range 0.3x – 0.9x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg 2.3x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $1.22B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.41B
Q. Revenue: $587.30M
TTM EBITDA: $666.00M
TTM Op. Income: $-84.60M
Q. Op. Income: $-200.20M
TTM Net Income: $-334.00M
Q. Net Income: $-268.60M
EPS: $-0.42
Shares Out.: $639.40M

$2.41B in TTM revenue declined 3.5% YoY, reaching $587.30M last quarter. TTM EBITDA of $666.00M and TTM operating income of $-84.60M show growth is flowing through to the bottom line. However, net income is negative at $334.00M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has fallen for 3 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 68.4%
EBITDA Margin: -2.5%
Op. Margin: -34.1%
Net Margin: -45.7%

Op. margin of -34.1% is down 35.2% YoY — costs are rising relative to revenue. Net margin at -45.7% and gross margin of 68.4% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has fallen for 3 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.5x
P/B Ratio: 0.3x

P/S of 0.5x and P/B of 0.3x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $10.49B
Cash: $217.70M
Long-Term Debt: $4.21B
Book Value: $4.54B
D/E Ratio: 0.9
Debt/EBITDA: N/A

With $10.49B in assets and $4.21B in long-term debt, D/E is 0.9and book value is $4.54B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has risen for 2 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $98.70M
TTM Free Cash Flow: $327.60M
FCF Margin: 13.6%
FCF / Net Income: -1.0

TTM FCF of $327.60M on $98.70M in operating cash flow. The FCF / Net Income ratio of -1.0x means the business consumes cash — it is not yet self-funding. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.